Abstract E-cigarette or vaping use-associated lung injury (EVALI) remains a major concern due to ongoing use of nicotine and/or cannabis-containing…
Abstract About half (54.2%) of adults who used electronic vapor products (EVPs) vaped nicotine only. Only 7.4% of adults who…
Abstract PED/UC nurses and physicians endorsed an EMR-embedded CDSS to reduce child TSE. Professionals liked the brief CDSS electronic prompts…
Abstract Since the initial reports regarding the nationwide outbreak of e-cigarette or vaping product use-associated lung injury (EVALI) in August…
Abstract Electronic cigarette, or vaping, products (EVP) heat liquids (“e-liquids”) that contain substances (licit or illicit) and deliver aerosolized particles…
Abstract E-cigarette or vaping use-associated lung injury (EVALI) was identified with the incidents of a multi-state outbreak of acute lung…
Abstract As of February 2020, over 2800 cases of lung injury associated with vapes have been reported in all 50…
Abstract Rationale: Opioids are effective medications, but they have several key limitations including the development of tolerance, establishment of dependence,…
Abstract Vaping products containing cannabidiol (CBD), a cannabis-derived compound used in wellness products and available in all 50 US states,…
Abstract Background: e-Cigarette or vaping-induced lung injury (EVALI) causes a spectrum of CT lung injury patterns. Relative frequencies and associations…